Fushida: Net profit in the first quarter of 2026 was 92.4685 million yuan, a year-on-year decrease of 20.12%.

Fosun Pharma announces that its revenue in the first quarter of 2026 was 609 million yuan, an increase of 2.52% year-on-year. Net profit was 92.4685 million yuan, a decrease of 20.12% year-on-year.